0001231919-22-000065.txt : 20221110 0001231919-22-000065.hdr.sgml : 20221110 20221110131324 ACCESSION NUMBER: 0001231919-22-000065 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221110 DATE AS OF CHANGE: 20221110 EFFECTIVENESS DATE: 20221110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MapLight Therapeutics, Inc. CENTRAL INDEX KEY: 0001770069 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-464468 FILM NUMBER: 221376213 BUSINESS ADDRESS: STREET 1: 501 2ND STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: 919-641-8778 MAIL ADDRESS: STREET 1: 501 2ND STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 FORMER COMPANY: FORMER CONFORMED NAME: Alvarado Therapeutics, Inc. DATE OF NAME CHANGE: 20190307 D 1 primary_doc.xml X0708 D LIVE 0001770069 MapLight Therapeutics, Inc. 800 Chesapeake Drive Redwood City CA CALIFORNIA 94063 (207) 653-8478 DELAWARE Alvarado Therapeutics, Inc. Corporation true 2018 Christopher A Kroeger 800 Chesapeake Drive c/o MapLight Therapeutics, Inc. Redwood City CA CALIFORNIA 94063 Executive Officer Director George Pavlov 800 Chesapeake Drive c/o MapLight Therapeutics, Inc. Redwood City CA CALIFORNIA 94063 Director Robert Malenka 800 Chesapeake Drive c/o MapLight Therapeutics, Inc. Redwood City CA CALIFORNIA 94063 Director James Lillie 800 Chesapeake Drive c/o MapLight Therapeutics, Inc. Redwood City CA CALIFORNIA 94063 Executive Officer Peter Bisgaard 800 Chesapeake Drive c/o MapLight Therapeutics, Inc. Redwood City CA CALIFORNIA 94063 Director Jonathan Gillis 800 Chesapeake Drive c/o MapLight Therapeutics, Inc. Redwood City CA CALIFORNIA 94063 Executive Officer Anatol Kreitzer 800 Chesapeake Drive c/o MapLight Therapeutics, Inc. Redwood City CA CALIFORNIA 94063 Executive Officer Erin Foff 800 Chesapeake Drive Redwood City CA CALIFORNIA 94063 Executive Officer Biotechnology Decline to Disclose 06b false 2022-10-25 false true true The underlying shares of common stock issuable upon conversion. false 0 11999999 11999999 0 false 1 0 0 0 false MapLight Therapeutics, Inc. /s/ Jonathan Gillis Jonathan Gillis Chief Financial Officer 2022-11-10